Skip to content

Zevra Therapeutics, Inc. ZVRA Total Current Assets

Total Current Assets at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$4.61B+32.8%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$657M-6.0%
XER
Xeris Biopharma Holdings, Inc.XERS
$251.68M+53.9%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$53.25M+6.6%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$417.63M+178%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$658.46M-11.0%

Other financials

Income statement

See full
Revenue$36.2M+77.5%
Gross profit$34.3M+80.1%
Operating income$52.1M+1,073%
Net income$37.9M+1,323%
EPS (diluted)$0.60+1,100%

Balance sheet

See full
Cash & equivalents$95.6M+156%
Total debt$1.1M-98.1%
Total equity$205.8M+402%
Total assets$278.6M+61.3%

Cash flow

See full
Operating cash flow$6.1M+175%
CapEx$35.0K-64.6%
Free cash flow$6.1M+173%

Valuation

See full
Market cap$773.23M+56.4%
Enterprise value$678.78M+30.8%
P/E6.2×
P/S6.3×-5.9×

Profitability

See full
Gross margin86.1%+7.2pp
Operating margin-103.9%-43.0pp
Net margin101.6%+60.1pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity100.7%+60.3pp
Debt / equity-1.5×
Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s total current assets?
Zevra Therapeutics, Inc. (ZVRA) reported total current assets of $229.97M in Q1 2026.
How has Zevra Therapeutics, Inc.'s total current assets changed year-over-year?
Zevra Therapeutics, Inc.'s total current assets increased by 181.9% year-over-year, from $81.57M to $229.97M.
What is the long-term trend for Zevra Therapeutics, Inc.'s total current assets?
Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s total current assets has grown at a 92.7% compound annual growth rate (CAGR), from $8.38M to $223.01M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.